"Ranitidine": ntuziaka maka ojiji

A, ọgwụ "Ranitidine", na-emepụta ụdị mbadamba, ntekwasa nri casings, erikpu 150 ma ọ bụ 300 milligrams. Active mgwa - ranitidine bụ ugbu na Nwa dị ka hydrochloride.

Pharmacological Njirimara nke ọgwụ, "Ranitidine" ntuziaka na-akọwa na ndị na-esonụ ụzọ. The agwọ ọrịa bụ ifịk gị n'ụlọnga megide karịrị H2 ihe nnabata eriri afọ mkpụrụ ndụ. Ọ bụ ike belata secretion nke hydrochloric acid, nke na-ebilite n'ihi na ihe nke baroreceptors, nakwa dị ka nri bufee, elu mmiri ọgwụ ọrụ, na ihe nke biogenic stimulators nke ihe na-gastrin na histamine.

Ranitidine hydrochloride nwere ike ibelata ego nke gastric ihe ọṅụṅụ, na-belata ịta nke hydrochloric acid nime ya. The agwọ ọrịa nwere ike ịkpọlite onye Onyenwe anyị + na afo, na nke a, n'aka nke ya, na-ebelata pepsin. Ọ bụrụ na ndị agwọ ọrịa na-ndinọ na a therapeutically na-atụ aro na nke ezi uche doses nke ranitidine hydrochloride emetụtaghị prolactin. Ọ nwekwara ike inhibiting na microsomal enzymes, na mmetụta nke nọ n'ọrụ umi bụ awa 12 mgbe na-anata a na-atụ aro dose.

Nkwadebe "Ranitidine" ntuziaka na-atụ aro iji na ihe banyere ndị na-esonụ ọrịa:

- maka ọgwụgwọ nke gastric ọnyá na mgbochi;

- duodenal ọnyá afọ ;

- Zollinger-Ellison syndrome.

The ọgwụ dị irè n'ịgwọ symptomatic na nrụgide onya, ọ na-eji na Nchikota maka mgbochi na-agwọ na postoperative oge.

Mgbe n'itinye nkwadebe "Ranitidine" ntụziaka adọ aka ná ntị nke na o kwere omume contraindications. Dị ka ihe atụ, ọ na-ekwu na ọgwụ kwesịghị iji n'oge ime na-emeso ụmụ n'okpuru afọ 14, nakwa dị ka n'ebe ndị ọrịa nwere a hypersensitivity ka ranitidine hydrochloride.

Anya ga-eji na ọnụnọ nke ọgwụ na onye ọrịa nke gbasara akụrụ ma ọ bụ hepatic ọdịda.

Guide tụrụ aro na-ewere mkpụrụ ọgwụ "Ranitidine" bụghị mmiri mmiri, n'agbanyeghị nri oge.

Ọnụọgụ ọgwụ na oge nke dosing na-ekpebisi ike site na ọdịdị na ogo nke ọrịa. N'ihi ya, ihe exacerbation nke duodenal ọnyá afọ ma ọ bụ na afo, ma ndị okenye ma ụmụaka afọ iri na anọ na afọ, ọ na-atụ aro ka ọ họpụta ma ọ bụ 150 mg (abụọ kewara doses kwa ụbọchị), ma ọ bụ na-eketa otu mpaghara 300 mg n'abalị. Dị ka a dọkịta nkwanye na dose nwere ike mụbara 450 mg. Dị ka a mgbochi ụfọdụ, n'ihi na ndị a ọrịa, na ọgwụ a na-eji na 150 mg dose na alakpu ụra.

Na ọgwụgwọ nke Zollinger-Ellison syndrome, ọgwụ ndinọ thrice kwa na mbụ ogbo nke omume (150 mg) na mgbe ahụ kwa ụbọchị dose nwere ike zụlitere ka 600-900 mg dabere na ọrịa na-arịa.

N'ihi na ọgwụgwọ nke ọnyá ọgwụ etinyere ugboro abụọ n'ụbọchị na 150 mg, a na-enye ọnya banyere a ọnwa.

Mgbe na-eji a ọgwụ na-akpọ "Ranitidine", ntụziaka stipulates ekwe omume nke mmetụta, ma ha na-egosi nnọọ mgbe. Nwere ike ime ọrịa isi ọwụwa, ike ọgwụgwụ, na rashes na akpụkpọ. Nnọọ obere okwu nke ntutu isi ọnwụ.

Akpan akpan ịkpachara anya ga-gosipụtara na ọrịa na-ewere ọgwụ, na ndị nwere a dysfunctional imeju ma ọ bụ gbasara akụrụ-aghasa.

Ọ bụrụ na ọ na-amalite na-egosi mmetụta mgbe na-ewere ọgwụ - kwusi oru, na nke a ga-a jiri nwayọọ nwayọọ na Mbelata ke onunu ogwu.

Irè nke ọgwụ mgbe ọ dị elu karịa onye prophylactic eji na mmiri na ụbịa.

Nkwadebe "Ranitidine" esịne ke ndepụta dị oké mkpa, bụ nke e mma site Russian ọchịchị, ya mere ya, mmejuputa iwu na-ere ọgwụ na netwọk nke pụrụ iche, ala ahịa.